Wockhardt gets USFDA nod for generic cancer drug

Wockhardt's Imatinib Mesylate tablets are a generic version of Gleevec, marketed in USA and other countries by Novartis.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2AWMZR2
via IFTTT

0 comments:

Post a Comment